LEP and metabolic dysfunction-associated steatohepatitis: Under other conditions, Chitturi et al. observed that serum leptin was not an independent predictor of hepatic inflammation or fibrotic severity and that hyperleptinemia observed in NASH could not be explained simply by gender, obesity, or the presence of type 2 diabetes [194].